Infection of tissue culture cells with vaccinia virus results in the specific secretion of several polypeptides into the medium. Previous studies identified a protein of approximate Mr 3 5 000 (3 5K) which was secreted in large amounts at both early and late times after infection with the Evans strain. We now show that a related protein is secreted by the Lister strain but not by WR, Wyeth nor Tian Tan. The gene encoding the Lister strain 35K protein was mapped within the inverted terminal repeats of the genome. The DNA sequence of this region showed that the ends of this gene are very similar to previously published sequences flanking a gene of WR which encodes a protein of approximate Mr 7500 (7.5K). Our results suggest that the 7.5K polypeptide of WR may have arisen as a result of a deletion event and is a truncated form of the 35K Lister protein. Site-directed mutagenesis demonstrated that the 35K secreted protein encoded by Lister is not essential for growth in tissue culture.
Introduction
Vaccinia virus, the prototypic poxvirus, contains a linear dsDNA genome of approximately 185 kbp with inverted terminal repeats (ITRs) of approximately 10 kbp that are cross-linked at each end (Geshelin & Berns, 1974; Garon et al., 1978; Wittek et al., 1978) . The genome encodes more than 100 genes which are regulated in a temporal fashion (reviewed by Moss, 1985) . Early genes are transcribed shortly after entry of the virus into the host cell. Late genes are switched on at the start of viral DNA replication. The transcription of viral genes occurs in the cytoplasm and is mediated by virus-encoded enzymes independent of the host cell transcriptional machinery (Moss, 1985) .
Vaccinia virus encodes several polypeptides, mainly of unknown function, that are secreted from the infected cell (McCrae & Pennington, 1978; Stroobant et al., 1985; Kotwal & Moss, 1988) . Using the Evans vaccine strain of vaccinia virus, McCrae & Pennington (1978) identified a polypeptide with an apparent M~ of approximately 35 000 (35K) which was secreted into the medium in large amounts at early times by infected cells and continued to be synthesized and secreted at late times during the virus growth cycle.
More recently Kotwal & Moss (1988) reported the nucleotide sequence of a gene encoding a 35K polypeptide secreted by cells infected with the Western Reserve (WR) strain of vaccinia virus, the most widely used strain in vaccinia virus research. However the DNA sequence suggests that this protein is probably expressed at late times in the virus growth cycle since both a late transcriptional start site (TAAATATG; Rosel et al., 1986) and an early transcriptional termination signal (TTTTTNT; , which frequently occurs within the coding region of late genes, are present. These features increase the probability that the 35K (Evans) and 35K(WR) secreted proteins may be different.
In this paper we compare the secretion of polypeptides of approximately 35K from cells infected with five different strains of vaccinia virus and show that both the Evans and Lister strains induce the synthesis of large amounts of a secreted 35K polypeptide throughout the viral growth cycle. The 35K(Evans) and 35K(Lister) secreted proteins are immunologically related; we have mapped and sequenced the gene which encodes the Lister protein. Interestingly we find that this gene is related, not to the gene encoding the 35K(WR) secreted protein of Kotwal & Moss (1988) , but rather to a gene of that virus which encodes a polypeptide of about 7.5K (Venkatesan et al., 1981) 
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Wyeth and Tian Tan (M. Mackett and J. Arrand, Paterson Institute of Cancer Research, Manchester, U.K.) were propagated on either rabbit kidney (RK), baby hamster kidney (BHK) or CV-1 cells in Dulbecco's ' modified Eagle's medium supplemented with 5% foetal calf serum (EFC5). Stocks of the virus were prepared as described by Joklik (1962) . Confluent monolayers of cells in the 15 mm diameter wells of multi-well plates were infected with vaccinia virus as indicated in the text. After 1 h at 37 °C, the inoculum was removed and replaced with fresh EFC5 for a further 1-5 h. The medium was then removed, the monolayers were washed in phosphate-buffered saline (PBS) and 0.1 ml PBS containing 50 gCi [3SS]methionine (Amersham) was added. At the end of the labelling period the PBS (containing secreted proteins) was collected. The cells were washed with PBS, harvested by scraping, lysed by repeated freezing and thawing and the cell debris was removed by centrifugation. The secreted proteins and cell extracts were analysed either directly, or after immunoprecipitation, on polyacrylamide gels (Laemmli, 1970) . All immunoprecipitations were performed as described by Zweig et al. (1980) .
Purification of" the 35K potypeptide. Confluent RK celis in roller bottles were infected with 25 p.f.u./cell vaccinia virus strain Lister in 10 ml EFC5 for 1 h at 37 °C. Fifty ml EFC5 was added, and incubation continued for 1.5 h. The cells were then washed with PBS and incubation was continued in 3 ml PBS for a further 3 to 4 h. The quantity of PBS added was just enough to keep the cells moist during this period.
[3sS]Methionine (220 gCi/bottle) was usually added to label the secreted proteins. PBS containing secreted proteins was collected from the roller bottles, centrifuged briefly to remove any cells, and then subjected to overnight lyophilization. After resuspension in distilled water (10~ of the original volume) the proteins were dialysed overnight against 50 mM-HEPES pH 7-5 (HEPES buffer) and loaded onto a DE52 cellulose (Pharmacia) ion-exchange column of 4.5 ml bed volume preequilibrated with HEPES buffer. After washing with 20 ml HEPES buffer, proteins were eluted from the column in a linear salt gradient from 0 to 0.5 M-NaC1 in HEPES buffer. The 35K polypeptide eluted at about 50 mM-NaC1. All manipulations were performed at 4°C. Electrophoresis of the purified fraction on a polyacrylamide gel revealed only low levels of contamination with other proteins (data not shown).
Preparation of antiserum. Antisera were produced in rabbits by immunization with an emulsion containing 2.5 mg of the purified 35K(Lister) protein in Freund's complete adjuvant. Subsequent boosts used Freund's incomplete adjuvant and 1.2 to 2-5 mg of the purified protein per boost. Booster injections were given 3, 4, 6 and 7 months after the primary injection. Ten days after the last boost, rabbits were bled out and antisera were prepared. The experiments described in this paper used one antiserum, 18691.
In vitro translation. Total cytoplasmic RNA was prepared from infected or mock-infected cells at late times post-infection (p.i.) as described (Maniatis et al., 1982) . Micrococcal nuclease-treated rabbit reticulocyte lysate (Amersham) was incubated at 30 °C for 1 h with RNA in the presence of [3SS]methionine according to the manufacturer's instructions. The proteins were immunoprecipitated using antiserum 18691 and analysed on a polyacrylamide gel.
DNA manipulations. A library of HindllI and HindlII-plus XhoIcleaved vaccinia virus strain Lister DNA was constructed in plasmid pATI53 (Twigg & Sherratt, 1980) . Clones representing all of the vaccinia virus genome except the terminal HindlII fragments B and G were obtained (Fig. 3 a) . To clone these fragments viral DNA was first treated with S1 nuclease to remove the terminal cross-links and blunt ends were produced with T4 DNA polymerase. The DNA was then cleaved with HindlII and fragments B and G were purified following agarose gel electrophoresis. Fragment G was ligated to pUC19 (Yanisch-Perron et aL, 1985) cleaved with Sinai and HindlII and used to transform Escherichia coli DH5 cells. Plasmid pG7 which contains the expected insert of approximately 10.8 kbp was purified from one transformant (Fig. 3b) . The S1 nuclease-treated and purified HindIII B fragment was cleaved with SstI, ligated to pUC19 cut with Sinai and SstI and transformed into E. coli cells. The resulting plasmid, pB48, contains an insert of approximately 9-8 kbp corresponding to the terminal SstI fragment (Fig. 3b) .
The 2-2 kbp BamHI plus SalI fragment of HindIII G which encodes the majority of the 35K protein was cloned between the corresponding sites of pUC 19 to yield plasmid pG62. The remainder of the protein is encoded by the overlapping XbaI fragment of plasmid p48-15 (Fig. 3 b) . The Sail fragment from p48-15 was cloned in the correct orientation in the SalI site of pG62 to form pG620 which contains the entire gene (Fig. 3b) .
Construction of a recombinant vaccinia virus carrying the fl-galactosidase gene in the 35K locus. The plasmid pD356 is essentially similar to pG620 except that nucleotides 1526 to 232l inclusive (ScaI to ClaI sites, Fig. 4 ) have been replaced by the sequence ACTCAATCAATAG-CAATTATGGATCCGATCT. This plasmid therefore contains a BamHI site (underlined) immediately downstream from the normal ATG codon but lacks the coding sequences of the 35K gene. The sequence upstream from the ATG codon remains unchanged. The lacZ gene, isolated on a BamHl fragment from pSC8 (Chakrabarti et al., 1985) , was inserted in frame into the newly created BamHI site to form pD357 (Fig. 5a ). The plasmid pD357 carries the DNA sequence from left of the 35K gene [35K(L)], the 35K promoter followed by lacZ, and DNA sequences from right of the 35K [35K(R)] gene (Fig. 5a ). Calcium phosphate-precipitated plasmid pD357 was transfected into CV-I cells infected with wild-type vaccinia virus strain Lister and a recombinant virus (blue plaque) was isolated as reported previously (Mackett et al., 1984; Chakrabarti et al., 1985) .
Hybrid-arrested translation (HART) of infected cell mRNA. This was performed as described by Paterson et al. (1977) . Briefly, infected cell RNA was hybridized with vaccinia virus DNA fragments. DNA was heated to 100 °C in the presence of 80% deionized formamide, 60 raM-PIPES pH 7.4. mRNA and NaC1 (50 mM final concentration) were rapidly added and annealing was allowed to occur overnight at 43 °C. The hybrids were precipitated with ethanol. After resuspension of the pellet in 6 gl H20, half of the sample was denatured by boiling for 1 rain and then placed on ice. The non-denatured and denatured (hybridreleased) samples were translated in vitro in the presence of [3sS]methionine, immunoprecipitated and analysed on polyacrylamide gels.
DNA sequencing. The BamHl to Sail fragment and the XbaI fragment carrying vaccinia virus sequences from plasmids pG62 and p48-15 respectively were isolated by electroelution following agarose gel electrophoresis. Small fragments obtained by sonication were cloned into M 13mp8 (Bankier et al., 1987) and the DNA sequenced by the dideoxynucleotide chain termination method of Sanger et al. (1977) using buffer gradient gels (Biggin et al., 1983) . Nucleotide sequence data were read directly into a computer from the autoradiographs. Random data were assembled into a contiguous sequence using programs DBUTIL and DBAUTO (Staden, 1982) . Both DNA strands were sequenced completely.
Results and Discussion

Analysis of polypeptides secreted by cells infected with different vaccinia virus strains
The original observation of a 35K polypeptide secreted in large quantities at both early and late times from vaccinia virus-infected cells used the Evans vaccine On: Wed, 17 Apr 2019 22:50:56
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:5 : 7 : : strain (McCrae & Pennington, 1978) . We confirmed these observations and further tested the ability of other vaccinia virus strains (namely WR, Wyeth, Lister and Tian Tan) to produce this polypeptide. Only cells infected with the Lister or Evans strains appeared to secrete 35K polypeptides in large quantities at both early and late times (Fig. 1) . We chose the Lister strain for further work because restriction maps are available for this strain (Mackett & Archard, 1979; Schfimperli et al., 1980; Esposito & Knight, 1985) . The 35K protein secreted by cells infected with the Lister strain was purified by DE52 cellulose ionexchange chromatography and used to raise antiserum 18691. The ability of the antiserum to precipitate the 35K polypeptide secreted by cells infected with both the Evans and Lister strains indicated that these polypeptides are immunologically related (Fig. 2) . Interestingly, the Evans polypeptide usually migrated as two bands. The ability of the antiserum 18691 to react with both suggested that they might represent differently processed forms of the same protein. Cells infected with strains WR, Wyeth and Tian Tan did not secrete any major polypeptide that reacted with the antiserum (Fig.  2) .
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When m R N A from cells infected with strains Lister, Evans or W R was translated in vitro and immunoprecipitated with antiserum 18691, polypeptides of 35K were seen with m R N A from Lister and Evans but not W R (Fig. 2) . This is consistent with this protein representing the in vitro equivalent of the secreted 35K protein. Other polypeptides precipitated from the in vitro translation reactions were also precipitated from cell extracts (Fig. 2 ) and may represent highly immunogenic proteins present as low-level contaminants in the 35K polypeptide preparation used for immunization. None of these proteins was precipitated by control antisera (data not shown). No 35K polypeptide (or obvious precursor) was precipitated from extracts of cells infected with strains Lister or Evans, confirming that its secretion is a very rapid process (McCrae & Pennington, 1978) .
A polypeptide of approximately 34K secreted by WRinfected cells at early times during infection was not precipitated by antiserum 18691 (Fig. 2) . It is possible that this polypeptide is the WR-encoded '35K' secreted A. H. Patel and others polypeptide reported by Kotwal & Moss (1988) . If this is the case then it is interesting to note that this polypeptide appeared in the medium of infected cells at early times only (Fig. 1) although its initiation codon forms part of a late transcriptional start site (Kotwal & Moss, 1988; Rosel et al., 1986) . Recently Smith et al. (1989) have shown that a vaccinia virus gene encoding a protein with extensive homology to DNA ligase and apparently carrying a late transcriptional initiation site is transcribed early during infection.
The purified Lister strain polypeptide yielded a partial N-terminal sequence of-Ala -Leu Gln Gln (-A-LQQ). The sequence beyond position 6 could not be obtained, possibly due to the presence of the adjacent glutamine residues (B. Dunbar, personal communication).
Mapping of the sequence encoding the 35K polypeptide by HART
mRNA from cells infected with strain Lister was annealed to vaccinia virus DNA fragments, translated in vitro, and the products were immunoprecipitated with antiserum 18691. Translation of the precursor to the 35K polypeptide (identified in Fig. 2) was efficiently arrested by a mixture of fragments representing the entire vaccinia virus strain Lister genome and synthesis was restored by denaturing the DNA-RNA hybrids prior to translation (Fig. 3c) . Specific DNA fragments from throughout the Lister genome were then tested for their ability to arrest the in vitro translation of the 35K polypeptide. In initial experiments cloned fragments representing the whole genome except the terminal HindIII B and G fragments (Fig. 3 a) all failed to arrest translation (data not shown). In contrast, the terminal HindIII fragments B and G purified from digests of vaccinia virus Lister DNA both arrested the translation of the 35K polypeptide (Fig. 3c) suggesting that the protein is encoded by a gene contained within the ITRs and therefore present at two copies per genome.
The terminal HindIII B and G fragments of Lister DNA were cloned in pUC19, forming plasmids pB48 and pG7 respectively (Fig. 3b) . Another plasmid, pG62, was constructed by cloning a BamHI to SalI fragment of the terminal HindIII G fragment into pUC19. Vaccinia virus strain Lister DNA, the plasmids above and a number of other cloned vaccinia virus DNA fragments (1 to 4, Fig. 3b ) were used in HART experiments to examine their ability to block the translation of the 35K polypeptide. As shown in Fig. 3(c) , pG7 and pB48 both arrested the translation of the 35K polypeptide. Of the other vaccinia virus DNA fragments tested (1 to 4), only the 3.2 kbp XbaI fragment arrested the translation of this polypeptide; the 1.2 kbp XbaI to BamHI, 1-8 kbp XbaI to SstI and 1-4 kbp XbaI fragments all failed to arrest translation. These results indicate that the gene encoding the 35K secreted polypeptide is located within the 2.2 kbp region between the BamHI and SalI sites (Fig. 3c) . The plasmid pG62 carrying this BamHI to SalI fragment of HindIII G also arrested translation (Fig. 3c) confirming the location of the gene within the ITRs of the Lister strain genome.
Nucleotide sequence of the region encoding the 35K polypeptide
The DNA sequence of the entire 2.2 kb BamHI to SalI fragment revealed only one open reading frame (ORF) with the potential to encode a polypeptide of approximately 35000 Mr. This longest ORF encodes 235 amino acids and is orientated towards the ends of the genome (Fig. 3) , extending beyond the SalI site at its C terminus. The remainder of this gene (downstream of the SalI site) was determined by sequencing an overlapping cloned XbaI DNA fragment. The complete gene encodes a further 23 amino acids giving a predicted Mr for the protein of 27 831 (Fig. 4) . Experiments described below verify that the 35K secreted protein is the product of this gene. The BamHI site is located approximately 6 kbp from the ends of the genome.
Comparisons of this Lister strain DNA sequence with the limited sequence reported for this region of the strain WR genome (Venkatesan et al., 1981) revealed several interesting features.
The sequences flanking the ends of the 35K gene were almost identical to the sequences reported at the ends of the 7-5K gene encoded by strain WR (Venkatesan et al., 1981) . Residues 1267 to 1579 at the 5' end and 2405 to 2568 at the 3' end of the 35K(Lister) gene are 98.7 ~o and 100~ identical to sequences at the 5' and 3' ends of the WR-encoded 7.5K gene ( Fig. 4 ; Venkatesan et al., 1981) . The promoter regulating the expression of the 35K gene in strain Lister-infected cells is thus identical to that of the 7.5K gene of strain WR. The 7.5K promoter is widely used for heterologous gene expression in vaccinia virus, and has been characterized extensively (Cochran et al., 1985; Davison & Moss, 1989) . Transcription is initiated at different sites during gene expression at early and late times ( Fig. 4 ; Cochran et al., 1985) , but the same polypeptide is produced upon translation. The regulatory sequences for early and late expression are located within 31 nucleotides of the respective transcription initiation sites (Cochran et al., 1985) .
At the 3' end of the gene, the hexanucleotide CTATTC is tandemly repeated three times followed by a closely related sequence, CTATTTC, which has been identified as the mRNA termination site (Venkatesan et al., 1981) . 
Interestingly a region of the cowpox virus ITR (Pickup et
On
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~3 5 K A 19 bp sequence (doubly underlined in Fig. 4 ) within the N -t e r m i n a l coding sequence of the Lister-encoded 35K gene is absent from strain W R and as a consequence introduces a translational frameshift. Therefore beyond a m i n o acid 12 quite unrelated polypeptides are specified T TCACTCATCGAT TCAACAAAAC TCAAAGCGTGTGTC TGAATCGATAAC TC TAT TCATCTGAAATTGGATGAGTAGGGT TAAT CGAACGAT TCAGGCACACCACGAAT TAAAAAAGTGTA 2400 Clal ~Sai~ Venkatesan et al., 1981) . The early (E) and late (L) transcriptional start sites and the 3' end of the gene encoding the WR 7-5K polypeptide (Venkatesan et al., 1981 ; Cochran et al., 1985) , and the relevant restriction sites are underlined. The 19 bp within the N-terminal coding sequence of the 35K gene present in strain Lister but absent from strain WR is doubly underlined. The other sites at which the DNA sequence of the strain WR upstream region differ from the strain Lister sequence are indicated by asterisks. The deduced signal peptide cleavage site is indicated by an arrow.
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L M K Q Y I V 6 TAAATACAATAATTAATTTCTCGTAAAAGTAGAAAATATAT TCTAATTTATTGGACGGTAAGGAAGTAGAA TCATAAAGAACAGTACTCAATCAATAGCAATTATGAAACAATATATCG T 1560 E - Sc~ * I L A C M C L A A A A M~P A S L Q Q S S S S S S S C T E E E N K H H M G I D V I I 46 CC TGGCATGCA TGTGCCTG~CGGCAGC TGC TATGCCTGCCAGTCTTCAGCAATCATCCTCATC CTCC TCCTCGTG TACGGAAGAAGAAAACAAACATCATATGGGAATCGATGTTATTAT 1680 Cl a I K V T K Q D Q T P T N D K I C Q S V T E I T E S E S D P D P E V E S E D D S T S 86 CAAAGTCACAAAGCAAGACCAAACACCGACCAATGATAAGAT T TGCCAATCCGTAACGGAAAT TACAGAGT CCGAGTCAGATC CAGATCCCGAGGTGGAATCAGAAGATGA TTCCACAT C 1800 V E D V D P P T T Y Y S I I G G G L R M N F G F T K C P Q I K S I S E S A D G N 126 AGTCGAGGATGTAGATCCTCCTACCAC TTATTACTCCATCATCGGTGGAGGTCTGAGAATGAACTTTGGAT TCACCAAATGTCCTCAGATTAAATCCATCTCAGAATCCGCTGATGGAAA 1920 T V N A R L S S V S P G Q G K D S P A I T R E E A L A M I K D C E V S I D I R C 166 CACAGTGAATGC TAGATTGTCCAGCGT GTCCCCAGGACAAGGTAAGGACTCTCCCGCGA TCAC TCGTGAAGAAGC TC TT GC TA TGATCAAAGACT GTGAGGTGTCTATCGACATCAGATG 2040 S E E E K D S D I K T H P V L G S N I S H K K V S Y E D I I G S T I V D T K C V 206 TAGCGAAGAAGAGAAAGACAGCGACAT CAAGACCCATCCAGTAC TCGGGTC TAACATCTCTCATAAGAAAG TGAG TTACGAAGATATCATCGG fT CAACGATCGTCGATACAAAA TGTGT 2160 K N L E F S V R I G D M C K E S S E L E V K D G F K Y V D G S A S E G A T D D T 246 CAAGAATCTAGAGTT TAGCGTTcGTATcGGAGACATGTGCAAGGAATCATCTGAACTTGAGGTCAAGGATGGATTcAAGTATGTcGACGGATCGGcATcTGAAGGTGCAAccGATGATAC 2280 XbaI SalI S L I D S T K L K A C V - 258
CCGGACAC TATATTC CGGT TTGCAAAACAAAAATG T TC T TAAC TACAT TCACAAAAAGT TACC TCTC GCGACT TC TTC T T T T T CTGT C TCAATAGTGTGATACGATTATGACACTAT TCC 2520
by the two strains. The two predicted amino acid sequences d!verge after residue 12 of the Lister 35K polypeptide and, based upon the downstream sequence from Lister, the WR polypeptide is expected to be only 57 amino acids in length. (The sequence of this region of WR DNA has not been reported.) The mRNA encoding the 7.5K(WR) polypeptide is 1200 nucleotides in length and therefore contains approximately 900 nucleotides of untranslated sequences . These findings suggest that the Lister-encoded 35K polypeptide represents the natural wild-type protein and that the 19 bp deletion in strain WR relative to Lister gives rise to a truncated coding sequence. This inference is consistent with our experimental evidence that strain WR does not encode a 35K polypeptide with properties similar to 35K(Lister). Kotwal & Moss (1988) recently reported the DNA sequence of a strain WR secreted polypeptide of a similar size to 35K(Lister), but analysis of this sequence reveals that the two proteins are in fact completely unrelated. Furthermore the WR-encoded 35K gene is located in the left-hand terminal HindlII fragment but outside the ITR and it shows no sequence homology to the Lister-encoded 35K gene we have described. The WR-encoded 35K polypeptide is structurally related to the superfamily of complement control proteins (Kotwal & Moss, 1988) .
The N-terminal end of the 35K(Lister) polypeptide contains a hydrophobic region of 17 amino acids which could potentially function as a signal sequence for secretion. Adjacent to this, the predicted amino acid sequence is PASLQQ. This sequence corresponds to the limited amino acid sequence we obtained earlier for the N terminus of DE52 cellulose-purified 35K polypeptide (-A-LQQ) providing good evidence that the sequenced gene encodes the secreted 35K polypeptide of strain Lister virus. The site of cleavage of the signal peptide can 6) . The size heterogeneity displayed by the smaller terminal fragment of virus V357 is typical of that seen in the terminal region of vaccinia virus DNA .
be deduced from the N-terminal sequence of the secreted protein as occurring after amino acid 17. Although the Evans strain-encoded 35K secreted polypeptide was reported not to be glycosylated (McCrae & Pennington, 1978) we note the presence of a potential Nlinked glycosylation site (NIS) at amino acid positions 184 to 186 in the deduced sequence of the 35K(Lister) polypeptide. It is not known whether this potential glycosylation site is utilized in strain Lister.
Analysis of the DNA sequence presented in Fig. 4 revealed that ORFs other than that coding for the 35K polypeptide are all less than 85 amino acids long (data not shown). A search of the Swissprot and NBRF protein databases using the program FASTA (Pearson & Lipman, 1988) failed to reveal significant homology of the Lister 35K polypeptide or the smaller ORFs to known proteins.
Construction of recombinant lacZ-vaccinia virus
The observation that three out of five vaccinia virus vaccine strains tested do not express proteins with the properties of 35K(Lister) suggest that this polypeptide may be non-essential for virus replication in vitro and in vivo (Fig. 1) . To test this hypothesis in tissue culture cells, and to provide conclusive evidence that the gene sequenced encodes the 35K secreted protein, we constructed a plasmid vector, pD357, in which the 35K coding region was deleted and replaced by the E. coli flgalactosidase (lacZ) gene placed under the control of the 35K promoter (Fig. 5a ). The 35K promoter-laeZ gene construct was flanked by sequences left and right of the 35K gene (Fig. 5a ) to facilitate its insertion by homologous recombination into the 35K locus of the strain Lister genome.
The recombinant virus V357 was selected on the basis of the blue colour produced in the presence of 5-bromo-4-chloro-3-indolyl-fl-D-galactopyranoside (X-gal) in infected cells. Southern blot hybridization confirmed that the lacZ gene had been inserted into the 35K locus in both ITRs of the V357 genome (Fig. 5e) . DNA of V357 and the parental strain Lister virus was cleaved with HindIII and probed with the BamHI fragment carrying the lacZ gene, the ClaI fragment from within the 35K gene of strain Lister, and the HpaI to NruI fragment carrying the entire 35K gene including its flanking sequences (Fig.  5c ). Two fragments of the V357 recombinant virus hybridized to the lacZ probe whereas the Lister DNA failed to hybridize (Fig. 5 e) . In contrast, probing with the ClaI fragment from within the 35K gene revealed terminal HindlII fragments B and G in the Lister strain whereas the recombinant V357 failed to hybridize (Fig.  5 c) . The fragments B and G of Lister DNA, and slightly larger corresponding fragments of V357, hybridized to the probe containing the entire 35K gene and its flanking sequences (Fig. 5c ). These data are consistent with replacement of both copies of the 35K gene by lacZ sequences having occurred in V357 by homologous recombination. Cells infected with V357 did not express detectable 35K polypeptide either in the medium or cell extract (Fig. 6) . However, as previously demonstrated, cells infected with the parental Lister strain secreted large quantities of 35K polypeptide which was precipitable with antiserum 18691 (Fig. 6) . To exclude the possibility that expression of lacZ might inhibit the expression of the 35K polypeptide in trans, another recombinant virus (V327) carrying the same 35K promoter-lacZ fusion inserted not into the 35K gene but into the thymidine kinase locus of the strain Lister genome was constructed. This virus retained the ability to express and secrete the 35K polypeptide (Fig. 6) . These results indicate that V357 fails to express and secrete the 35K polypeptide as a direct result of the deletion of the predicted 35K ORF. They confirm that the 35K secreted protein is encoded by this ORF (Fig. 4) , and show that its presence is not essential for virus growth in tissue culture. The function of the 35K secreted protein remains unknown.
